All Articles

With a 98.2% jet card renewal rate and major fleet expansion, the private operator's referral-driven success offers a lesson in high-end service.

CIRM's new RAPID program aims to revolutionize genetic therapy, using scalable platforms to bring hope to millions with rare diseases who have no options.

As SmartStop sets its Q4 earnings date, investors watch to see if its aggressive expansion and acquisition spree can translate into sustained profitability.

A Las Vegas mother won a life-changing $350,000 prize just by guessing home prices on her phone. Is this the future of achieving the American Dream?

Luxury brand QWEEN partners with London's Dalziel & Pow to swap intimidating counters for immersive stores, aiming to reshape how India buys jewellery.

With $161M in sales, Roger Pettingell's team again ranks No. 1 for Coldwell Banker, blending digital mastery with deep local roots to thrive in a complex market.

Facing a cash crunch after a major clinical trial setback, the cancer vaccine developer is exploring a sale or merger, putting its pipeline at risk.

A landmark partnership between TotalEnergies and Galp is set to unlock billions of barrels of oil, positioning Namibia as a new global energy powerhouse.

As Sagicor sets to unveil its 2025 year-end financials, investors eye key metrics and strategic shifts in a complex economic landscape.

Alberta’s innovative permit system is hailed as a model for Canada, but critics question if speed comes at a cost. See who else is fighting red tape.

An explosion at Centerra Gold's Langeloth facility has injured workers, suspended operations, and sent shockwaves through the global molybdenum market.

TotalEnergies and Galp deepen their partnership in the Orange Basin, meeting with Namibia's President to fast-track the nation's rise as a new energy hub.

A federal grant to 5N Plus aims to boost domestic germanium production, a key material for night vision and satellites, directly challenging foreign supply chains.

Nuwellis appoints Carisa Schultz as CFO, a strategic move to leverage her public company expertise as it navigates growth and financial challenges.

A $10M investment from pharma giant Dr. Reddy’s validates Coya Therapeutics' novel ALS drug, funding the path to commercial-scale manufacturing.

The acquisition of TSI Auto Solutions is more than a deal; it's a strategic move reflecting Volaris's 'permanent home' philosophy in a consolidating market.

After Amgen steps back, Kyowa Kirin takes full control of its promising atopic dermatitis drug, rocatinlimab, betting on its unique science.

Zebra's RFID trackers are changing how the NFL is played, coached, and watched. Discover the tech behind Next Gen Stats and its reach beyond the gridiron.

Bonaccord Capital Partners' new award highlights its success in the booming GP stakes market and validates parent company P10's strategic middle-market focus.

The Cardinal Newman Society has honored Divine Mercy University for its unique integration of professional psychology with a faithful Catholic worldview.